When treating children with colds that are accompanied by a cough, Mucaltin Forte is recommended for the doctor's prescription. This drug is characterized by special pharmacological properties and composition. Dosage and the regimen are prescribed in the instructions for use.
Composition
Active ingredient: mucaltin is 100 milligrams.
Additional elements:
- magnesium carbonate;
- aspartame;
- tartaric acid;
- sucrose;
- calcium stearate;
- silicon dioxide;
- fragrance "Orange".
Pharmacological properties
Mucaltin Forte is an expectorant with bronchodilator and secretolitic action. Muciltin produces an average antitussive effect, reducing the intensity of coughing attacks and their frequency.
Mucus less viscous and sticky, contributes to the normalization of bronchopulmonary secretion, thereby facilitating the excretion of mucus.
Mukaltin forte does not produce a local irritant effect, nor is it toxic.
Indications
The drug is prescribed as an expectorant and an anti-inflammatory drug for children with:
- viral or respiratory diseases of the respiratory system, accompanied by a dry cough;
- pneumonia;
- traehobronchitis;
- tracheitis;
- bronchoectatic disease;
- emphysema.
Dosage and intake scheme
The optimal treatment for a child is a systematic Mukaltina intake an hour before eating three times a day. The dosage depends on the age of the patient:
- Three to seven years - on a pill.
- From seven and older - two tablets in one session.
You can apply the drug in the form of a solution: one tablet of Mucaltin accounts for one-third of a glass of warm boiled water.
Continue treatment until the time when a wet cough disappears. On average, the therapeutic course is from a week to two.
to the table of contents ^Side effects
Very rarely allergic reactions are possible, expressed as itching or urticaria, as well as headache, nausea, heartburn, diarrhea. If side effects occur, stop taking the drug.
In children suffering from chronic respiratory diseases, during the first treatment with Mucaltin may worsen expectoration by increasing the viscosity of mucus. This occurs in connection with the separation of accumulated sputum with a high content of proteins, detritus and bacteria that provoke inflammation. In this case, treatment should be continued: achieving a complex effect is possible with the administration of Muciltin in combination with mucolytic agents.
Contraindications
Mukaltin is not used to treat children under the age of one year.
It is contraindicated in patients with:
- thrombosis;
- thrombophlebitis;
- with severe kidney disease;
- diabetes.
In addition, there may be increased sensitivity to any of the components of the drug, for example, congenital fructose intolerance, glucose-galactose malabsorption syndrome and phenylketonuria.
The drug is not prescribed in combination with drugs that suppress cough.
to table of contents ^Overdose
When taking Mucaltin in recommended therapeutic doses, an overdose is not possible. Nausea or vomiting can occur if the drug is used or consumed for too long in too high quantities.